NEWS |  January 19, 2023

Sense Neuro Diagnostics Awarded Arizona Innovation Challenge

Commercialization Opportunity Grows MedTech Startup’s Presence in Grand Canyon State

CINCINNATI, OH – January 19, 2023 – Sense Neuro Diagnostics is getting ready to participate in the  Arizona Commerce Authority Venture Ready Accelerator, an initiative that helps startups refine business  plans, improve go-to-market execution strategies, and increase investor readiness. The opportunity to  participate comes after the MedTech startup was one of 10 awardees in last month’s Arizona Innovation  Challenge, a premier pitch competition that advances innovation and technology commercialization  opportunities in Arizona. 

The Cincinnati-based startup recently opened a second office in Phoenix in a strategic move to grow its  presence in Arizona. Last month, Sense Neuro Diagnostics announced that it had entered into a know-how  license agreement with the Mayo Clinic, and the startup is currently engaged with the Mayo Clinic and  Arizona State University MedTech Accelerator in Tempe, Arizona. 

Sense Neuro Diagnostics is developing innovative, non-invasive technology that can collect 360 data points  in 2.5 seconds to detect brain hemorrhage or stroke type. This technology has the potential to help first  responders, emergency department personnel, neuro ICU teams, and military field hospitals rapidly assess  and monitor traumatic brain injuries. 

“The Arizona Innovation Challenge and one of the largest business plan competitions in the country and a  great way for Sense to actively take steps toward commercialization,” says Geoffrey Klass, chief executive  officer, Sense Neuro Diagnostics. “Arizona is rich with resources and talented connections focused on  helping startups springboard to the next level, and Sense Neuro Diagnostics is pleased to be included in a  strong class of honorees.” 

More than 20 sites across the United States, Canada, and India are currently engaged in pivotal trials to  evaluate Sense Neuro Diagnostics’ in-hospital device, and five sites are evaluating its military field device. 

Behind the Science: Non-Invasive Brain Scanners

Time is brain. You’ll hear us say that a lot at Sense Neuro Diagnostics. We’re on a mission to aid personnel to detect, monitor, and manage brain conditions in real-time. Once a brain cell dies, there’s no getting it back. If you or a loved one is riding in an ambulance going to a hospital ill-prepared for a brain injury or waiting in the ER for a CT scan, those could be crucial moments slipping away that you’ll never get back, possibly resulting in permanent disability or death.

Sense Neuro Welcomes Eric Bailey as Chief Commercial Officer

Cincinnati, OH - Sense Neuro Diagnostics today announced the hiring of Eric Bailey as Chief Commercial Officer. With experience as a seasoned CEO and expertise in technical and operational responsibilities in startup businesses, specifically in the market areas Sense Neuro intends to enter, we are proud to welcome Bailey to the team.

US FDA New Clinical for Sense Neuro Diagnostics

The new trial approved by the FDA Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices will begin as soon as June 2023 and involve up to 300 patients at 30 sites in the United States, as well as Canada and India.

St. Elizabeth Healthcare Invests $250,000 In Sense Neuro Diagnostics

Medical technology startup Sense Neuro Diagnostics has received $250,000 in funding from St. Elizabeth Healthcare in Edgewood, Kentucky. The investment will help Sense Neuro Diagnostics as the company advances clinical trials in its effort to commercialize a non-invasive technology to monitor traumatic brain injuries.

Sense Neuro Diagnostics Places Second In Unicorn Cup Finals Q4 2022

Cincinnati-based Sense Neuro Diagnostics is pursuing new international investment opportunities after coming in second place in the Unicorn CUP Finals startup competition. The pitch event is affiliated with Unicorn Events, the world’s largest startup pitch competition that focuses on discovering extraordinary startups that have the potential to achieve a valuation of $1 billion or more.